Health Care/Hospital
Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting
JINAN, China, March 4, 2024 /PRNewswire/ -- The European Society of Gynecological Oncology (ESGO) 2024 Conference has recently made selected abstracts available online. The abstract (abstract # 251) that details results from the Phase II clinical trial (DUBHE-C-206) evaluating the efficacy and s...
2024-03-04 16:53
1399
Caliway Announced Orphan Drug Designation Granted to CBL-514 for the Treatment of Dercum's Disease
* CBL-514 is the first and only drug to receive both Orphan Drug Designation and Fast Track designation for Dercum's disease treatment. NEW TAIPEI CITY, March 4, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan D...
2024-03-04 16:22
1219
THAILAND EXPECTS 25% GROWTH IN FITNESS AND MASS PARTICIPATION SPORTS FOR 2024
BASE Bangkok 'Asia's Gym of the Year' Partners with Hyrox Fitness Race to Further Elevate Physical Training inSoutheast Asia BANGKOK, March 4, 2024 /PRNewswire/ -- According to the Thai Mass Participation Sports Trade Association (TMPSA) over 1,500 mass participation sports such as marathons, ...
2024-03-04 09:00
2517
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children's Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2
FORT LEE, N.J., March 2, 2024 /PRNewswire/ -- Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr.Rahu...
2024-03-02 10:26
2881
The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China
NANYANG, China, March 2, 2024 /PRNewswire/ -- Co-hosted by the Nanyang Chinese Medicine Development Bureau, the China Association of Chinese Medicine (CACM) and the China Association of Traditional Chinese Medicine (CATCM), the Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Dev...
2024-03-02 05:10
3158
LIFE FITNESS ANNOUNCES PROMOTION OF ANDREW MAHADEVAN TO CHIEF COMMERCIAL OFFICER TO LEAD CONTINUED GROWTH
ROSEMONT, Ill., March 2, 2024 /PRNewswire/ -- Life Fitness, the global leader in commercial fitness equipment, is pleased to announce the promotion ofAndrew Mahadevan, Vice President & Managing Director, to Chief Commercial Officer, effectiveApril 1. Mr. Mahadevan's announcement follows the retir...
2024-03-02 02:00
2519
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories
* Kinnate has entered into an Asset Purchase Agreement (the "APA") with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets. * The transaction is in furtherance of Kinnate's previously announced pursuit of strategic alternatives. * This acquisition is ...
2024-03-01 21:35
3636
Thermo Fisher Scientific to Inaugurate New Office, Marking Milestone Expansion in Indonesia
Company to support advancements in country's science and technology sector, with a focus on progressing healthcare, environmental solutions, and food safety JAKARTA, Indonesia, March. 1, 2024 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, will significantly expand ...
2024-03-01 10:30
9709
Innovent Announces First Participant Dosed in a Phase I Study of IBI3002 (an anti-IL-4Rα/TSLP bispecific antibody) in Australia
ROCKVILLE, Md. and SUZHOU, China, March 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2024-03-01 08:00
2647
'An Urgent Public Health Necessity' - National Institute for Play Releases New Report Underlining Science and Power of Play
CARMEL VALLEY, Calif., March 1, 2024 /PRNewswire/ -- Amid complex global events and an ongoing mental health crisis, experts at theCalifornia-based National Institute for Play (NIFP) released today a comprehensive new report on the biology, benefits, and modern interpretations of play. The free ...
2024-03-01 06:20
2656
uLab® Celebrates One Million Aligner Treatments
MEMPHIS, Tenn., March 1, 2024 /PRNewswire/ -- uLab Systems® announces it has achieved its one millionth order for a clear aligner treatment plan. The milestone was reached when Dr.Melanie Wang from Dr. Melanie Orthodontics created a uDesign® treatment plan for clear aligner therapy and ordered th...
2024-03-01 02:42
1939
Metabolon Unveils New Integrated Bioinformatics Platform
Metabolon's cutting-edge bioinformatics platform and unique knowledge base will enable customers to leverage the company's extensive biochemistry experience MORRISVILLE, N.C., Feb. 29, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide var...
2024-02-29 20:58
1547
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency
Collaboration will harness Medidata Electronic Clinical Outcome Assessment
(eCOA) for remote patient engagement and real-time data capture
SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Medidata
2024-02-29 17:40
1469
ANICAV advocate the importance of legumes in the Australian diet as the days get colder
SYDNEY, Feb. 29, 2024 /PRNewswire/ -- As autumn creeps into Australia and
temperatures begin to drop, the Legumes From Europe
2024-02-29 15:00
2262
Overseas Brand WALOVI of Wanglaoji Made Its Debut Globally to Share the Eastern Health Philosophy with the World
GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- Wanglaoji unveiled its international overseas brand "WALOVI" globally at the 2024 Milan-Guangzhou Business Environment Promotion Conference and China-Italy Economic and Trade Cooperation and Exchange Meeting onFebruary 26th. The theme of the event w...
2024-02-29 14:03
1609
Allianz Partners appoints Jacob Fuest as Chief Markets Officer and Board Member
Jacob will focus on profitable growth of Allianz Partners business units across the globe and brings a strong leadership background NEW DELHI and PARIS, Feb. 29, 2024 /PRNewswire/ -- Allianz Partners, a world leader in insurance and assistance services, has announced the nomination of Jacob Fuest...
2024-02-29 13:30
1436
Nin Jiom, Modern Chinese Medicine Pioneer, to Launch NMN Supplement for Healthy Ageing
SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Nin Jiom
2024-02-29 11:00
1445
MGI Tech & Juntendo University: Changing the Landscape and Unlocking Answers for Patients with Rare Diseases
TOKYO, Feb. 29, 2024 /PRNewswire/ -- Rare diseases have historically been overlooked because they affect relatively few people. While they are identified and addressed differently around the world, there are over known 6,000 rare diseases – characterized by a wide range of disorders and symptoms...
2024-02-29 09:00
1924
Huawei Launches the Medical Technology Digitalization Solution to Accelerate Intelligence in Healthcare
BARCELONA, Spain, Feb. 28, 2024 /PRNewswire/ -- During MWC Barcelona 2024,
Huawei officially launched its Medical Technology Digitalization Solution as
part of its effort to lead the digital and intelligent upgrade of the
healthcare industry.
2024-02-28 22:14
1686
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease
SKY-0515 is a small molecule RNA splicing modifier developed through the company's novel SKYSTAR® platform. Having successfully advanced through single asending dose, SKY-0515 is advancing into the Multiple Ascending Dose portion of its phase 1 study. Huntington's disease is a fatal neurological ...
2024-02-28 21:32
1201
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2924
